Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04797806
Status:
UNKNOWN
Last Update Posted:
2021-03-15
First Post:
2021-03-12
Brief Title:
Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC
Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Organization:
Tianjin Medical University Cancer Institute and Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-12
First Submit QC Date:
March 12 2021
Study First Post Date:
2021-03-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-12
Last Update Post Date:
2021-03-15
Last Update Post Date Type:
ACTUAL